A

Applied Therapeutics

D
APLT
USD
0.09
(0.9326%)
Market Closed
63,852.00
Volume
-0.829
EPS
-
Div Yield
-6.811189
P/E
1,118,602,679.54
Market Cap
Today
0.9326%
1 Week
10.181%
1 Month
26.494%
6 Months
101.865%
12 Months
295.935%
Year To Date
190.746%
All Time
0%

Title:
Applied Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
Do you need help or have a question?